The Investigator Program at Chan Zuckerberg Biohub–San Francisco is funding research by world-renowned scientists, engineers, and technologists from Stanford University, UC Berkeley, and UCSF. This funding is unrestricted, giving these extraordinary Investigators the freedom to pursue their most exciting, visionary ideas. Many of these bold, innovative projects involve the invention of new tools and techniques that accelerate the pace of scientific discovery and help CZ Biohub realize its vision of curing, preventing, or managing every disease by the end of the century.
In early 2022, we announced the newest cohort of Investigators. These Investigators began their awards on March 1, 2022. In early 2026, we will announce the next call for applications from faculty members at our partner universities (Stanford, UC Berkeley, UCSF) for five-year awards beginning March 2027.
We’re also pleased to welcome 15 new university-nominated investigators, recently appointed to faculty positions by our partners. As with all Investigators in the CZ Biohub SF Investigator Program, these university-nominated scientists received $1 million in unrestricted funds over five years, and will have the opportunity to collaborate with, learn from, and inspire their fellow Investigators.
The Intercampus Research Awards have supported cutting-edge research for collaborative, multi-institution teams. Each cross-disciplinary team includes faculty members from our three partner universities. By working together, these investigators have developed new technologies and advance our understanding of some of the most demanding challenges in biomedical research.
Meet the Investigators
David Cox, M.D., Ph.D.
Stanford University, Starting July 1, 2025
Walter Gonzalez, Ph.D.
Christopher Hernandez, Ph.D.
HAO LI, PH.D.